Definition of biosimilar in English:

biosimilar

noun

  • A biopharmaceutical drug designed to have active properties similar to one that has previously been licensed.

    ‘copycat drug makers use an innovator's research data to make biosimilars’
    • ‘The drug is being developed as a biosimilar to Herceptin.’
    • ‘Now it's true that some patent expirations expected in the 2011-2013 timeframe have been pushed out, and it's also true that biosimilars could be a sizable opportunity.’
    • ‘So far, the only country where a Celltrion-made biosimilar is on the market is South Korea.’
    • ‘We have no idea at this point whether this biosimilar will prove efficacious.’
    • ‘The United States wants to learn more about how other TPP countries "address the issue of biologics and biosimilars before proposing any specific provisions," she said.’
    • ‘Expertise in injectables could also help when the market for biosimilars, or copycat biotechnology drugs, opens up.’
    • ‘Patients will either get the biosimilar or actual Rituxan.’
    • ‘I can add another example, the cost of developing a biosimilar that costs around 30 million.’
    • ‘Considerable investment is also needed to produce a biosimilar and bring it to market.’
    • ‘Generic drugmakers are pushing into the field of biosimilars as global pharmaceutical companies face the loss of patent protection on many established drugs.’
    • ‘Presently the company is developing a biosimilar of the antibody, a drug with dramatic therapeutic effects for rheumatoid arthritis.’
    • ‘The complexity of biosimilars has led to a drawn-out process and more questions posed by the industry.’
    • ‘Based on European experience, Amgen could sell its biosimilar at a price discount of 15-20 percent versus Neupogen upon launch.’
    • ‘Since these agents are not considered bioequivalent, the pharmacy cannot substitute a biosimilar for the branded version.’
    • ‘Biosimilars will have to be advertised and explained.’
    • ‘The attractiveness of biosimilars, regardless of the product, is you'll always have limited competition because of the complexity and the investments required to make such medicines.’
    • ‘The first-ever approved biosimilar, Omnitrope (somatropin), arrived on the European market in 2006.’
    • ‘Also discussed in detail are success factors for the emerging biosimilar industry and the regulatory environment in emerging markets with respect to biosimilars.’
    • ‘The process to develop a biosimilar is more complex than that of developing a generic copy of a chemical-based compound.’
    • ‘FDA has not approved tbo-filgrastim as a biosimilar to Neupogen (filgrastim).’

Origin

Early 21st century: from bio- + similar.

Pronunciation:

biosimilar

/bʌɪə(ʊ)ˈsɪmɪlə/